ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_7_length_42818_cov_25.6746_24 # 28412 # 28627 # 1 # ID=7_24;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.667	NODE_7_length_42818_cov_25.6746_24 	28412	28627	+	Loose	400	22.7126	MUS-2	35.9	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	ATGCCTCGCGGAAACACCAAGAAGGAGCAGCGCAAGCGCTGGGCGCAGTGGGAGGCGTACCGAAACGAGATGTACGTGACCGACGAGAAGGCCCTCGCCCGCGCCTACCGCGAGTACAGCCTGACTGGCGTACTGGAGGACCCGTGGACCGGGGACCGGTACTGCCCGTCCTGCGAGAAGCCCGAGCAGTACTGCGACTGCGGCTCCGTCGCCTGA	MPRGNTKKEQRKRWAQWEAYRNEMYVTDEKALARAYREYSLTGVLEDPWTGDRYCPSCEKPEQYCDCGSVA	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	28.86	gnl|BL_ORD_ID|2169|hsp_num:0	2328
NODE_141_length_9396_cov_5.52468_4 # 3764 # 4324 # 1 # ID=141_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.565	NODE_141_length_9396_cov_5.52468_4 	3764	4324	+	Strict	500	23.483	mphB	100.0	3000318	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCCCCAGCGAAGCGAGCAGGCTTGGGTCTTGCGCTCACCGGGGTGCTGTCGCTCAGCGCGTGTGGAGCGGGCAATGTCAATCTTGATCCGGCTCCAGATGCCGCCAACCCCGTATGCGCTTATGCGATGGTTGCTATGCCAGAAAAACTCGTTGGCTTACAGCAGCGTGAAACTACGGCGCAAGGAACGACCGCTTGGGGCGAACCAGCCTCCGTGATTCTCAAATGCGGTGTTACCGTTCAGGAACCCGTATCGGACCCATGCGCTGAGGTCAATGGGATTGATTGGGTGCTGCGTCCCAAGGATGCGCCAGAGAACTCAGCACCGCCAGTCTCTGCGTCTTCCTCCGCCGCTGCAGGCCCTGAAAACCGTGCGACGGGAACGTGGACGGCAACCACGTACGGACGAACGCCCGCCATTGAAGTAACCTTCGACGCAGATAAGGTTTCATCATCAACTCTTCTTGCTGAGCTCAACTCGGCGGTCAAACAAATTCCGTCTCAGAAGAAATGCACGAACATCAACGATACTCTCAACGGTGTCAAAACCGGAAAATAG	MSPAKRAGLGLALTGVLSLSACGAGNVNLDPAPDAANPVCAYAMVAMPEKLVGLQQRETTAQGTTAWGEPASVILKCGVTVQEPVSDPCAEVNGIDWVLRPKDAPENSAPPVSASSSAAAGPENRATGTWTATTYGRTPAIEVTFDADKVSSSTLLAELNSAVKQIPSQKKCTNINDTLNGVKTGK	MSKDIKQVIEIAKKHNLFLKEETIQFNESGLDFQAVFAQDNNGIDWVLRLPRREDVMPRTKVEKQALDLVNKYAISFQAPNWIIYTEELIAYKKLDGVPAGTIDHNIGNYIWEIDINNVPELFHKSLGRVLAELHSIPSNKAAALDLVVHTPEEARMSMKQRMDAVRAKFGVGENLWNRWQAWLNDDDMWPKKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSHDFIFNYRAFGEEGLEALILAYKEIGGYYWPKMKEHIIELNAAYPVSIAEFALVSGIEEYEQMAKEALEVQGS	61.59	gnl|BL_ORD_ID|1653|hsp_num:0	1731
NODE_152_length_9141_cov_7.25105_9 # 6549 # 7037 # -1 # ID=152_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.378	NODE_152_length_9141_cov_7.25105_9 	6549	7037	-	Strict	1200	340.117	tetM	98.15	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGAAGGGATACGCTATGGCTGTGAACAAGGATTGTATGGTTGGAATGTGACGGACTGTAAAATCTGTTTTAAGTATGGCTTATACTATAGCCCTGTTAGTACCCCAGCAGATTTTCGGATGCTTGCTCCTATTGTATTGGAACAAGTCTTAAAAAAAGCTGGAACAGAATTGTTAGAGCCATATCTTAGTTTTAAAATTTATGCGCCACAGGAATATCTTTCACGAGCATACAACGATGCTCCTAAATATTGTGCGAACATCGTAGACACTCAATTGAAAAATAATGAGGTCATTCTTAGTGGAGAAATCCCTGCTCGGTGTATTCAAGAATATCGTAGTGATTTAACTTTCTTTACAAATGGACGTAGTGTTTGTTTAACAGAGTTAAAAGGGTACCATGTTACTACCGGTGAACCTGTTTGCCAGCCCCGTCGTCCAAATAGTCGGATAGATAAAGTACGATATATGTTCAATAAAATAACTTAG	MEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	MKIINIGVLAHVDAGKTTLTESLLYTSGAIAESGSVDTGTTRTDTTFLERQRGITIQTAVTSFQWKDIKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISARDGVQAQTRILFHALNKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIEGNDYLLEKYTLGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGRSVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT	25.35	gnl|BL_ORD_ID|1618|hsp_num:0	1692
NODE_334_length_6651_cov_3.5595_7 # 4159 # 5364 # 1 # ID=334_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.434	NODE_334_length_6651_cov_3.5595_7	4159	5364	+	Strict	600	788.104	tet(A)	99.75	3000165	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATAGTTCGACAAAGATCGCATTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCTGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACAGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCGCTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACACGTGATAATACAGATACCGAAGTAGGGGTTGAGACGCAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACACTCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTGCTTAG	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVAFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	100.00	gnl|BL_ORD_ID|1858|hsp_num:0	1808
NODE_334_length_6651_cov_3.5595_9 # 6158 # 6574 # 1 # ID=334_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.360	NODE_334_length_6651_cov_3.5595_9	6158	6574	+	Perfect	250	283.493	tet(D)	100.0	3000168	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTATATTGAACAGCATTCTCGCTATCAAAATAAAGCTAATAACATCCAATTAAGATATGATGATAAGCAGTTTCATACAACGGTTATCAAAGATGTTCTATTATGGATTGAACATAATTTAGATCAGTCTTTACTGCTTGATGATGTGGCGAATAAAGCGGGTTATACCAAGTGGTATTTTCAGCGGCTGTTCAAAAAAGTAACAGGGGTCACACTGGCTAGCTATATTCGTGCTCGTCGTTTGACGAAAGCGGCTGTTGAGTTGAGGTTGACGAAAAAAACTATCCTTGAGATCGCATTAAAATATCAATTTGATTCCCAACAATCTTTTACACGTCGATTTAAGTACATTTTTAAGGTTACACCAAGTTATTATCGGCGTAATAAATTATGGGAATTGGAGGCAATGCACTGA	MYIEQHSRYQNKANNIQLRYDDKQFHTTVIKDVLLWIEHNLDQSLLLDDVANKAGYTKWYFQRLFKKVTGVTLASYIRARRLTKAAVELRLTKKTILEIALKYQFDSQQSFTRRFKYIFKVTPSYYRRNKLWELEAMH	MYIEQHSRYQNKANNIQLRYDDKQFHTTVIKDVLLWIEHNLDQSLLLDDVANKAGYTKWYFQRLFKKVTGVTLASYIRARRLTKAAVELRLTKKTILEIALKYQFDSQQSFTRRFKYIFKVTPSYYRRNKLWELEAMH	100.00	gnl|BL_ORD_ID|1239|hsp_num:0	1138
NODE_585_length_5366_cov_3.16061_1 # 1 # 342 # 1 # ID=585_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.471	NODE_585_length_5366_cov_3.16061_1 	1	342	+	Loose	400	23.0978	vanRI	26.32	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TGGGTGCAATCGTTAATCGCAGATTGGGGAATGCAAGCCAGTTTTGACCAAGCGAAAGCGTGGTTTGAAGTTTGGGGCGTAGCAGTGGTTTTCTTGGCAGGTTTCTCGCCCATTCCGTATAAAGTCTTCACCATTTGTGCGGGGGTAATGCAAATGGCGTTCTTCCCGTTTGTGATTACTGCCGCTGTTTCCCGCTTTACTCGCTTTATTTTGGTGGCGAAGCTCTCCGCGTGGGGCGGTGAAAAATATGCGGATAAAATCCGTCGTTCGATCGAATTGATTGGCTGGGGTACAATTGCCTTGGCTGTAGTCGCTTATACTATTTATCAGTTAACTAAATAA	WVQSLIADWGMQASFDQAKAWFEVWGVAVVFLAGFSPIPYKVFTICAGVMQMAFFPFVITAAVSRFTRFILVAKLSAWGGEKYADKIRRSIELIGWGTIALAVVAYTIYQLTK	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	48.71	gnl|BL_ORD_ID|2118|hsp_num:0	2246
NODE_658_length_5176_cov_28.8959_5 # 1270 # 2733 # -1 # ID=658_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_658_length_5176_cov_28.8959_5	1270	2733	-	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_658_length_5176_cov_28.8959_6 # 2853 # 4070 # -1 # ID=658_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_658_length_5176_cov_28.8959_6 	2853	4070	-	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_705_length_5001_cov_4.20946_2 # 485 # 1831 # -1 # ID=705_2;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.569	NODE_705_length_5001_cov_4.20946_2 	485	1831	-	Loose	1300	25.7942	vanTG	40.91	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAGCGAATCCGTAGCCGGACAGAACACCGGCAGCACGCATCAAAACCTAACGGCAGGGGAGAGTGAACAGGATGCGCGGGCACAGAAATTAGCCCGTACCGGCGTACCCTACGCTCTTAATACCGCAGCGGCATGGTCGTGGCGTCTGATCGTGGTGGTCGGTGCCGTGTGGCTTGTATGGCAGGGGCTTTCAAAGGTGTCTCTGCTGATTATTTCGGCGATGGTGGCTGCGCTTTTGGCTGCGCTTCTAAGCCCCGCCGTCTACGCTATGCGTAAGCACGGTATTCGTGCTGGCGGTGCGACCGCTATTGCCGAACTTGGCATGATTTTAGGAATTGCCGCTTTACTGGCCCTTACCGGGCAGCAGCTTGTGCGGGGGTTTGTCTCGCTTACCAACAACGCCATTCAAGGGTATCAGCAGCTCGTGGACTGGCTTAAGGGCATGGGGTATGAGCTGGGCGCTGATCAGCTTAACCAGATTCTTAATCAGATAGAACAGGCGGTGAGCAATAACCCCTCAACCGTTTTGCGGAGCGTATCAGAGGTTGGTTCTACCGCTGCGGAGTTTGCCACCGGCGTGCTTATTACTCTTTTTACCCTCGTCTTCTTCCTGATGGAGGGAGAGCGCATCTGGCTGTTTATCGTCAAGCTCTTCCCACAACAGGCACGCGATGCGGTGAACGGCGCGGGTCGTGCAGGGTGGAAGTCCCTGGGCGCTTATGTGCGGGTGCAGATCTTGGTGGCCGCTATTGACGCTGTGGGCATTGGTGTTGGCGCCGCCATTTTGGGGGTTCCGCTGGCGATTCCGCTGGGGGTTCTGGTTTTCTTAGGGTCTTTTATCCCGGTTATTGGCGCCCTTATTTCTGGGGCGGTCGCTGTCCTGCTGGCACTGGTAGCTTTGGGGCCGGTTCAGGCGCTCATTATGATCGGCATTGTGCTGTTGGTGCAGCAGCTCGAATCGCATATTCTGCAGCCGCTCATCATGGGTAAAGCGGTCTCGCTGCATCCGCTCGCCGTGATTTTTGCGGTGGCAGGCGGATCCATGATTTTCGGTGCAGCGGGTGCACTATTTGCGGTTCCCGTGCTCGCCGTCGTGAATTCGGTTGTGCGCTACTTGGCTGCACGGCAGTGGGAGGATGACCCGGAGCTGCGCCGTGAAGAGTTCCTCTTCCCGCATGAGGTTGAGCGCCGTGAGAAATCAAAAAAGCGTGAAGAAAAAGCACAGAAGGTTGTTGCGCAGGCGCGGGAAGCGATTCGTGGTGAAGACGATTCCGAAGGCACCGCACTTGAGACTAGCTCTGCACAGGCGACTAAAACTGTCTCGCCTTCTAAGGACGATACGTAA	VSESVAGQNTGSTHQNLTAGESEQDARAQKLARTGVPYALNTAAAWSWRLIVVVGAVWLVWQGLSKVSLLIISAMVAALLAALLSPAVYAMRKHGIRAGGATAIAELGMILGIAALLALTGQQLVRGFVSLTNNAIQGYQQLVDWLKGMGYELGADQLNQILNQIEQAVSNNPSTVLRSVSEVGSTAAEFATGVLITLFTLVFFLMEGERIWLFIVKLFPQQARDAVNGAGRAGWKSLGAYVRVQILVAAIDAVGIGVGAAILGVPLAIPLGVLVFLGSFIPVIGALISGAVAVLLALVALGPVQALIMIGIVLLVQQLESHILQPLIMGKAVSLHPLAVIFAVAGGSMIFGAAGALFAVPVLAVVNSVVRYLAARQWEDDPELRREEFLFPHEVERREKSKKREEKAQKVVAQAREAIRGEDDSEGTALETSSAQATKTVSPSKDDT	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	62.92	gnl|BL_ORD_ID|1488|hsp_num:0	1561
NODE_2354_length_2798_cov_2.41633_2 # 1673 # 2242 # -1 # ID=2313_2;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.344	NODE_2354_length_2798_cov_2.41633_2 	1673	2242	-	Strict	400	380.948	ErmF	98.94	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGAGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTTGA	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIEAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFF	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	71.05	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_3470_length_2303_cov_2.06005_1 # 448 # 588 # 1 # ID=3361_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.418	NODE_3470_length_2303_cov_2.06005_1 	448	588	+	Loose	1500	23.0978	rphA	40.0	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGAAAGAATTCAAAGAACTAAGCAAACAAGAGTTAGAGAAAACATGTGGCGGAGTTGCCATGCCTGCCTTATGGTTTTTTAGACGCCAAGCACCTTCAGGAAATCGACGGTCCTCTAGATTTTCACTTCTCATTCTCTAG	MKEFKELSKQELEKTCGGVAMPALWFFRRQAPSGNRRSSRFSLLIL	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	5.32	gnl|BL_ORD_ID|927|hsp_num:0	910
NODE_3585_length_2267_cov_4.74955_4 # 1930 # 2265 # -1 # ID=3466_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.339	NODE_3585_length_2267_cov_4.74955_4 	1930	2265	-	Loose	300	23.483	dfrG	18.84	3002868	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	AGTAAACCGATGTGTATAGGGCAAAAACAACGCTGGTTTTTGTTGCAGCTTGTCGGCGATGAAAAAAATATCAATATGCAAACAACCAAATCACCAGAATTTGATGGGTGGCGTTGGGTAAGTTTTTGGTATCCTGTTCGCCAAGTTGTGTCCTTTAAAAAGGATGTATATCGTAAGGCAATGAAGGAATTTTCTAACGTATTGTTCTCAGATAATCCTCCTATTCATACGACTATATATGATACAGAACAAAAGCATTATTCATATAATAAAAAGCGTAATACATCGAAATATTCTAAACGTCCGTTTTATAAAACAAGGAATAATTCATGCTAA	SKPMCIGQKQRWFLLQLVGDEKNINMQTTKSPEFDGWRWVSFWYPVRQVVSFKKDVYRKAMKEFSNVLFSDNPPIHTTIYDTEQKHYSYNKKRNTSKYSKRPFYKTRNNSC	MKVSLIAAMDKNRVIGKENDIPWRIPKDWEYVKNTTKGHPIILGRKNLESIGRALPDRRNIILTRDKGFTFNGCEIVHSIEDVFELCKNEEEIFIFGGEQIYNLFFPYVEKMYITKIHHEFEGDTFFPEVNYEEWNEVFAQKGIKNDKNPYNYYFHVYERKNLLS	67.27	gnl|BL_ORD_ID|419|hsp_num:0	448
NODE_4685_length_1951_cov_5.95886_2 # 655 # 1950 # -1 # ID=4449_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.406	NODE_4685_length_1951_cov_5.95886_2 	655	1950	-	Strict	900	818.15	hmrM	95.36	3003953	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GGATTAGCGGATACCAGTATGGCTGGTCGAGTGAGTTCCACTGATATGGCAGCGATTTCTGTTGGCGCATCGATTTGGATGCCGTTGGTGCTTTTCGGTCAAGGCTTATTATTGGCGCTACCACCGACTATTTCTTACCTAAACGGTTCAGGCCAACGCCATCGCATTGCCCATCAAGTTCGCCAAGGCATTTGGCTTGTGTTAGGCGTGAGTATTCCTTTAGGTTTGCTGATTTATTTCTGTGAAATTCCGCTGCAATATATGCAAATGGAAAGCAAAATGTCAGATTTAGCACGCGATTATTTACACGCCATGTTGTGGGGATTACCTGCTTATTTAATGCTGATTAATTTTCGTTGTTTAAATGATGGTATTGCCAAAACCAAGCCAGCAATGGTCATTACCTTTTTAGGTTTACTGCTGAATATTCCGCTTAATTACATTTTTATTTATGGAAAATTTGGTATGCCTGCTTTTGGTGCGGTGGGCTGTGGTATTGCGACAGCTATTGTGAACTGGGCAATGTGCTTAATGATGATTTTCTATTCCTACACCAATGCTCAAGAACGTTCACTAAAAGTATTTAGTCAATTAATTGAAATGCCGAATCCCAAAACGCTTAAAAAATTACTGCGTTTAGGCTTGCCCATTGCTATTGCACTTTGTTGTGAAGTGGCATTATTTGCCCTCACTTCGTTAATGCTTTCTCCGCTAGGCTCAACCGTTGTGGCGAGCCATCAAATTACATTGAATACCAGCTCTTTCATTTTCATGTTCCCCCTGTCAATTGGTATGGCAACAACGATTTTAGTCGGACAAGCATTGGGGGCAGGTTCTCCACAAAATGCGAAAAAAATGAGCTATGCCGCATTATTATTAGGGCTAACGGTGACAATCATTACTGCATTAATTACGATTTTCTTCCGTTATGAAATTGCCTCTATTTTCGTCACCGATGAAATTGTCATCGCCATGGCGGCAAATTTATTATTATTTGCCGCACTTTATCAATTTTCAGATACCATTCAAATGGTGGTTGGCGGCATTTTACGGGGCTATAAAGATACTAAAGTCATTTTATATATTACCCTTTTCTCTTATTGGGTAATTGGTGTGCCACTTGGTTATATACTGGGTCGTACAGATTGGCTTGTGCCACACATTGATGCGAAAGGTTTCTGGATTGCCTTTGTGGTCTCACTCACTTTTGCGGCGTTCTTGCTTTCTTTGAGAATGAAAAAAATGCAAGGCATGAGTGATAACGCTATTTTACAACGTTTAGAAAAACTCAAATAA	GLADTSMAGRVSSTDMAAISVGASIWMPLVLFGQGLLLALPPTISYLNGSGQRHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARDYLHAMLWGLPAYLMLINFRCLNDGIAKTKPAMVITFLGLLLNIPLNYIFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNAQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIALCCEVALFALTSLMLSPLGSTVVASHQITLNTSSFIFMFPLSIGMATTILVGQALGAGSPQNAKKMSYAALLLGLTVTIITALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYILGRTDWLVPHIDAKGFWIAFVVSLTFAAFLLSLRMKKMQGMSDNAILQRLEKLK	MNFRLLSQYHTDIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWMPLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARNYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNYIFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMATTILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPHIDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK	92.89	gnl|BL_ORD_ID|2219|hsp_num:0	2425
NODE_4813_length_1925_cov_13.423_1 # 2 # 442 # -1 # ID=4558_1;partial=10;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.458	NODE_4813_length_1925_cov_13.423_1 	2	442	-	Strict	750	287.73	pmrA	97.28	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACAGAGATTAACTGGAAGGATAATCTGCGCATTGCCTGGTTTGGTAATTTTCTGACAGGAGCCAGTATTTCCTTAGTTGTGCCTTTTATGCCTATCTTTGTGGAAAGTCTGGGTGTAGGGGGAGAGCAAGTTGCTTTTTATGCAGGCTTAGCTATTTCTGTCTCTGCTATTTCTGCGGCGCTTTTCTCTCCTATCTGGGGCATCCTTGCTGATAAATACGGTCGAAAACCCATGATGATTCGGGCTGGCCTGGCCATGACTATCACTATGGGAGGCTTGGCCTTTGTCCCAAATATCTATTGGTTAATCTTTCTTCGTTTACTAAACGGTGTATTTGCTGGTTTTGTTCCCAATGCAACGGCCCTGATAGCCAGTCAGGTTCCCAAGGAGAAATCAGGAACTGCCTTAGGTACTTTGTCTACAGGCGTAGTTGCAGGT	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVESLGVGGEQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGTALGTLSTGVVAG	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	36.84	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_5892_length_1715_cov_2.6988_2 # 379 # 489 # -1 # ID=5477_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.514	NODE_5892_length_1715_cov_2.6988_2 	379	489	-	Strict	500	19.631	CARB-6	100.0	3002245	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGGAAGTGTTTGGTCTCACATCATATACCTACGCCTTGGCCCCATTCCTCGTTACGGTAGATAACGAGTCGGTGAAGAATCGGATCGCCGGCAACCAACGTTTCCCGTAG	MEVFGLTSYTYALAPFLVTVDNESVKNRIAGNQRFP	MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSITAIVWSEEKKTIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR	12.50	gnl|BL_ORD_ID|601|hsp_num:0	641
NODE_6219_length_1668_cov_8.0465_1 # 1 # 141 # 1 # ID=5753_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.397	NODE_6219_length_1668_cov_8.0465_1 	1	141	+	Loose	700	21.1718	vanWI	35.29	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	GACGATAAAGAAATGTTAGAAGATTTAATCGCGGCCGCTTTTAACGATGCGGTACATCGTGCAGAAGAATTACAAAAAGAAAAAATGGCATCGGTTACCGCTGGAATGCCATTACCTCCAGGAATGAAGTTTCCATTTTAA	DDKEMLEDLIAAAFNDAVHRAEELQKEKMASVTAGMPLPPGMKFPF	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	12.33	gnl|BL_ORD_ID|2107|hsp_num:0	2242
NODE_8071_length_1434_cov_4.82886_2 # 655 # 1434 # -1 # ID=7219_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.391	NODE_8071_length_1434_cov_4.82886_2 	655	1434	-	Strict	900	480.33	hmrM	95.75	3003953	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	TGGGCAATGTGCTTAATGATGATGTTCTATTCCTACACGAATGCTCAAGAACGCTCGCTAAAAGTATTTAGCCAATTAATTGAAATGCCGAATCCCAAAACGCTTAAAAAACTACTGCGTTTAGGCTTGCCAATTGCTATTGCACTTTGTTGTGAAGTGGCGTTATTTGCCCTCACTTCGTTAATGCTTTCTCCGCTAGGCTCAACCATTGTTGCGAGCCATCAAATTACATTGAATACCAGCTCTTTCATTTTTATGTTCCCTATGTCAATTGGTATGGCAACAACGATTTTAGTCGGACAAGCATTGGGAGCTGGCTCACCACAAAATGCGAAAAAAATGAGCTATGCCGCATTATTATTAGGGCTAACGGTGACAATCATTACTGCATTAATTACGATTTTCTTCCGTTATGAAATTGCCTCTATTTTCGTCACCGATGAAATTGTCATCGCCATGGCGGCAAATTTATTATTATTTGCCGCACTTTATCAATTTTCAGATACCATTCAAATGGTGGTTGGCGGCATTTTACGGGGCTATAAAGATACTAAAGTCATTTTATATATTACCCTTTTCTCTTATTGGGTAATTGGTGTGCCACTTGGTTATATACTGGGTCGTACAGATTGGCTTGTGCCACACATTGATGCGAAAGGTTTCTGGATTGCCTTTGTGGTCTCACTCACTTTCGCAGCGATCTTACTTTCTTTGAGAATGAAAAAAATGCAAGCTATGAGCGATAACGCCATTTTACAACGTTTAGAAAAACTCAAATAA	WAMCLMMMFYSYTNAQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIALCCEVALFALTSLMLSPLGSTIVASHQITLNTSSFIFMFPMSIGMATTILVGQALGAGSPQNAKKMSYAALLLGLTVTIITALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYILGRTDWLVPHIDAKGFWIAFVVSLTFAAILLSLRMKKMQAMSDNAILQRLEKLK	MNFRLLSQYHTDIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWMPLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARNYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNYIFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMATTILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPHIDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK	55.82	gnl|BL_ORD_ID|2219|hsp_num:0	2425
NODE_8691_length_1369_cov_5.39269_1 # 3 # 332 # 1 # ID=7692_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.361	NODE_8691_length_1369_cov_5.39269_1 	3	332	+	Loose	500	23.0978	CTX-M-66	24.49	3001927	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	AGTAAACCGATGTGTATAGGGCAAAAACAACGCTGGTTTTTGTTGCAGCTTGTTGGCGATGAAAAAAATATCAATATGCAAACAACCAAATCACCCGAATTTGATGGGTGGCGTTGGGTAAGTTTTTGGTATCCTGTTCGTCAAGTTGTGTCGTTCAAAAAAGAAGTGTATCGCAAAGCGATGAAAGAGTTTTCGAGCGTGTTGTTCTCAGAAAATCCTCCTGTATATCAACCTACACGAGAATTGGAGCAAAAATCTTATACTCATCCTAAAAAATATAATGGTTCAAAATTTCCAAAACGTTCTTTTAATAAAACAAGGAATTCATAA	SKPMCIGQKQRWFLLQLVGDEKNINMQTTKSPEFDGWRWVSFWYPVRQVVSFKKEVYRKAMKEFSSVLFSENPPVYQPTRELEQKSYTHPKKYNGSKFPKRSFNKTRNS	MVKKSLRQFTLMATATVTLLLGNVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	37.46	gnl|BL_ORD_ID|1651|hsp_num:0	1729
NODE_10785_length_1202_cov_3.03139_1 # 128 # 1060 # -1 # ID=9219_1;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.359	NODE_10785_length_1202_cov_3.03139_1	128	1060	-	Strict	600	639.032	CfxA2	99.68	3003002	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	TTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTTATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	LSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	96.57	gnl|BL_ORD_ID|162|hsp_num:0	174
NODE_11336_length_1164_cov_2.37241_3 # 1009 # 1164 # 1 # ID=9609_3;partial=01;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.359	NODE_11336_length_1164_cov_2.37241_3 	1009	1164	+	Loose	550	22.7126	LRA-2	61.54	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGAATCGTAAAGATTTAATAGATCGATTACAAGAATTATATAAAGATGAAGATAGTCGGGTAACAGTAAATCCTCATGCAGGGCAAAAGGTGGCCATCGTCTATCCAAATACATACTTCGTGGGCATGAGTAATCTTGGACTTCATATCATTTAT	VNRKDLIDRLQELYKDEDSRVTVNPHAGQKVAIVYPNTYFVGMSNLGLHIIY	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	17.22	gnl|BL_ORD_ID|1265|hsp_num:0	1324
NODE_12432_length_1098_cov_3.98178_2 # 129 # 416 # 1 # ID=10339_2;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.306	NODE_12432_length_1098_cov_3.98178_2 	129	416	+	Loose	400	23.483	IMP-21	45.45	3002212	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	GTGAAGAAAAGAAAAATACCAACAAGAAAATGTATTTTAACAAATGAGATGTTTCCGAAGAAAGATTTATTACGAATCGTTAAAAATAAAGAAGGAGAAATCTCTGTTGACCCTTCAGGTAAACAAGCAGGTCGTGGTGCATATGTAGTTTCAGATTTAGAAGTTATTAAAGCTGCACAAGAAAAGAAACAGTTAGAGAAATTTTTCTCTGCATCACCAGAAGTTATGGAACCTATCTATAACGAAGTAATTAGATTAATTTATAGAAAGTCAATTCCACAAAAATAA	VKKRKIPTRKCILTNEMFPKKDLLRIVKNKEGEISVDPSGKQAGRGAYVVSDLEVIKAAQEKKQLEKFFSASPEVMEPIYNEVIRLIYRKSIPQK	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVASKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	38.78	gnl|BL_ORD_ID|978|hsp_num:0	1019
NODE_13303_length_1052_cov_4.45236_3 # 970 # 1050 # 1 # ID=10902_3;partial=01;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.654	NODE_13303_length_1052_cov_4.45236_3 	970	1050	+	Loose	500	20.7866	PER-7	34.78	3002369	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGGCACACAAGAAGGGTCTTGGTTCCTCCCGTAACGGCCGCGACTCCAACGCGCAGCGCCTCGGCGTCAAGCGCTTCGGC	MAHKKGLGSSRNGRDSNAQRLGVKRFG	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN	8.77	gnl|BL_ORD_ID|830|hsp_num:0	863
NODE_13714_length_1031_cov_3_2 # 826 # 1029 # 1 # ID=11150_2;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.397	NODE_13714_length_1031_cov_3_2 	826	1029	+	Loose	200	21.9422	ANT(3'')-IIb	45.45	3004090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGACAGCTCAAATTCAACAATTAACATCAGAATTAACTTTAGAACGTATCAATGAAATCCCTGTTTTAACCTTAAATCACCCTGTGGGTTCAGCTCGAATTGCATTACAAGGGGCACAGCTATTAAATTGGCAGCCTAAAGGGGCTGAGCAGGATATCTTTTGGCTAAGTGAGATTGAACCTTTTACACAAGGTGTCGCGATT	MTAQIQQLTSELTLERINEIPVLTLNHPVGSARIALQGAQLLNWQPKGAEQDIFWLSEIEPFTQGVAI	MSEQFQLQQLQEYLHALFAESLFAIYLYGSAVDGGLGPESDLDLLVVVTQPLTHVQRQQLAQALLTLSHPIGGLQRALEVTILLKEEVISGRYPLNYELQFGEWLREELVDGGELSAQNDPDISILLKKAHMHHRTLFGPDLTSWLDEIPDQQLWQAMADLYPSIVAHWDEDGDERNQILALCRIYFSLSLGEIVSKSHAAQWVIAQLEEKDQPVLQRMVQEYKGEMTKQDWPSQHQVLQPIVNFLSQHIETFFDKKGLKIKQ	25.86	gnl|BL_ORD_ID|2303|hsp_num:0	2754
NODE_14348_length_1003_cov_4.41245_3 # 907 # 1002 # -1 # ID=11557_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	NODE_14348_length_1003_cov_4.41245_3 	907	1002	-	Loose	900	19.631	ANT(3'')-Ii-AAC(6')-IId fusion protein	46.67	3002598	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6'); ANT(3'')	GCCCTTATGGGGCAGCGCGCCGGCGACACCGTCGCCTACGAGGCCCCCACCGGCCGGGAGATCCAGGCCCAGATAGTCAAGGTCGAGCGGGTCTGA	ALMGQRAGDTVAYEAPTGREIQAQIVKVERV	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	6.70	gnl|BL_ORD_ID|2069|hsp_num:0	339
NODE_15414_length_960_cov_3.30608_4 # 801 # 959 # -1 # ID=12200_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	NODE_15414_length_960_cov_3.30608_4 	801	959	-	Loose	400	23.483	MUS-2	35.9	3003842	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MUS beta-lactamase	TACCGAAACGAGATGTACGTGACCGACGAGAAGGCCCTCGCCCGCGCCTACCGGGAGTACAGCCTGACCGGGGTACTGGAGGACCCGTGGACCGGTGACCGGTACTGCCCCTCCTGCGAGAAGCCTGAGCAGTACTGCGACTGCGGCTCCGCTGCCTGA	YRNEMYVTDEKALARAYREYSLTGVLEDPWTGDRYCPSCEKPEQYCDCGSAA	MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGAILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTNEILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKSAEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQHSTKND	21.14	gnl|BL_ORD_ID|2169|hsp_num:0	2328
NODE_17601_length_882_cov_11.3736_1 # 3 # 218 # -1 # ID=13476_1;partial=10;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.398	NODE_17601_length_882_cov_11.3736_1 	3	218	-	Strict	600	21.557	Burkholderia pseudomallei Omp38	100.0	3004123	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAACGCGATTCAAGAATCATTTACTGATAAATTATTTGCCAACTATGAAGCAAATGTAAAATACCAAGCGATTGAAAATGCTGCCAGCCATAACGGAATTTTTGCAGCTCTAGAACGTCGCCAAAGCCATGTAGACAATACACCTGTTTTCTCATTGGATTTGACCAAGGACAAGGTAACAAACCAGAAAGCGTCTGGTCGTTGCTGGATGTTT	MNAIQESFTDKLFANYEANVKYQAIENAASHNGIFAALERRQSHVDNTPVFSLDLTKDKVTNQKASGRCWMF	MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQSRFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYDATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFSNNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQGRSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAYTYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTSINQTAATVGLRHRF	19.25	gnl|BL_ORD_ID|2317|hsp_num:0	2786
NODE_20507_length_800_cov_2.5302_2 # 605 # 799 # -1 # ID=15028_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.518	NODE_20507_length_800_cov_2.5302_2 	605	799	-	Loose	500	22.3274	OXA-18	29.41	3001413	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GACGTCAACCTCCGCGCCTGCCATCATCCTGAATTCGACGGCTGGCGTTGGCATCAATATTGGGCGCCGGTTGACGAAGTCATCGACTTCAAGCGCGGCGTGTATTTGGGCGCATTGACCGAACTTTCCCGTTTCTTGCGCGGCATAGAAAGCTATGAAGAATTTATCCGTCGCAATCCAATAGAAAACCTATAA	DVNLRACHHPEFDGWRWHQYWAPVDEVIDFKRGVYLGALTELSRFLRGIESYEEFIRRNPIENL	MQRSLSMSGKRHFIFAVSFVISTVCLTFSPANAAQKLSCTLVIDEASGDLLHREGSCDKAFAPMSTFKLPLAIMGYDADILLDATTPRWDYKPEFNGYKSQQKPTDPTIWLKDSIVWYSQELTRRLGESRFSDYVQRFDYGNKDVSGDPGKHNGLTHAWLASSLKISPEEQVRFLRRFLRGELPVSEDALEMTKAVVPHFEAGDWDVQGKTGTGSLSDAKGGKAPIGWFIGWATRDDRRVVFARLTVGARKGEQPAGPAARDEFLNTLPALSENF	23.27	gnl|BL_ORD_ID|964|hsp_num:0	1003
NODE_21921_length_765_cov_2.09014_1 # 38 # 631 # 1 # ID=15790_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.463	NODE_21921_length_765_cov_2.09014_1 	38	631	+	Loose	600	26.5646	AAC(6')-30/AAC(6')-Ib' fusion protein	23.64	3002599	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACAAATCCTTTAGAACGATTAGTAGAAGAGTTGCGTCGCCTACCAGGTGTGGGGGCTAAATCGGCTAGACGATTAGCATACCATTTGATTGAGGCAGATGCAGAAGATGTACAACGCTTGGTAGAAACCATCCTTGCAGCGAAAGAAGCGACTCATAGATGTTCCCAATGCTTTAATTTATCAGCTCAAGATCCTTGTGAGTTTTGTGCTAGCTCTAAACGGGACAGATCGATGATTTGTGTGGTGGAAACATCCCGTGATGTCATCGCCATCGAACGCAGTGGTGACTATAAAGGGCTATACCATGTGTTGGAAGGGGCTTTGTCCCCTATTGATGGGGTAGGCGTAGAAGACATCCGCTTGAAAGAGCTCATGTTGCGCCTTCAAGATAATACAGTGCAAGAGGTTATCATCGCCACAGATCCTGATGTAGAAGGGGAAGCAACGGCTCTATATATTGCTCGATTATTGCAACCTACGGGGATTAAGGTCACTCGTATTGCCCGTGGTATTCCTGTAGGCGGGGATATTGAATACGCTGATGAGGTGACCTTGAGCGGTGCTGTATTACATCGTCAAGAAATGAGGTAA	MTNPLERLVEELRRLPGVGAKSARRLAYHLIEADAEDVQRLVETILAAKEATHRCSQCFNLSAQDPCEFCASSKRDRSMICVVETSRDVIAIERSGDYKGLYHVLEGALSPIDGVGVEDIRLKELMLRLQDNTVQEVIIATDPDVEGEATALYIARLLQPTGIKVTRIARGIPVGGDIEYADEVTLSGAVLHRQEMR	MTFLIRPVEQSDAESWERLRNLLWEGDDHKSEITQFFNGEVEEPNEVLLAVTEENDAIAHIELSLRYDIDGLTGIKTGYIEGLFVEERHRAAGVVLKLLRAAEFWARDQGCLAFASDRDDRVIIYARYTGAPPNNSLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA	60.06	gnl|BL_ORD_ID|883|hsp_num:0	922
NODE_23373_length_733_cov_19.4366_1 # 3 # 398 # 1 # ID=16479_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.439	NODE_23373_length_733_cov_19.4366_1 	3	398	+	Loose	1900	23.483	acrB	26.23	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GGAAAATGGTATTTCTATGAGTCTGGTGATCTGAAGACAGGCTGGGTGAAAACAGGTGGTAAATGGTACTACTTGGATGACCTAGGTGTCATGCAGACAGGATTTGTAAAAGTAGATGGTAGCTGGTATTACTTGAGTAGCTCAGGTGCTATGTTTACAGGCTGGGGTACAGACGGAAATAGATGGTTCTACTTTGATGGCTCAGGAGCTATGAAGACAGGCTGGCTCAAAGAAAATGGAATCTGGTACTACCTTGATGCGTCTGGTATCATGAAGACAGGTTGGTTTAAAGTTGGCCAATACTGGTATTATGCATATGGCTCTGGAGCTTTGGCAGTCAGCACAACAACACCAGACGGTTATAAAGTAAATGGCAACGGTGAATGGGTAAACTAG	GKWYFYESGDLKTGWVKTGGKWYYLDDLGVMQTGFVKVDGSWYYLSSSGAMFTGWGTDGNRWFYFDGSGAMKTGWLKENGIWYYLDASGIMKTGWFKVGQYWYYAYGSGALAVSTTTPDGYKVNGNGEWVN	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	12.49	gnl|BL_ORD_ID|1055|hsp_num:0	1104
NODE_24546_length_709_cov_2.76453_2 # 412 # 708 # -1 # ID=17043_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	NODE_24546_length_709_cov_2.76453_2 	412	708	-	Loose	500	27.7202	CTX-M-122	32.61	3001981	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GACCTGGAGGCGGCACGTGGCGCCCTGGATGTCTTCGAGGTCGACGCCCTGGGCCTGGATCGTCTGGACCGCCAGGTGCTTGAGGCACTGTGCACCCGGTTCGGCGGCGGCCCGGTGGGGCTGACGACGCTGGCGGTCAGTGTGGGGGAGGAGCCCGAGACGGTGGAGACCGTGGCCGAGCCCTACCTCGTGCGCGAGGGGCTGGTGGTGCGTACCCCGCGGGGTCGGGCGGCCACGCCGGCTGCCTACAGCCACCTGGGACTTGAGCCCCCTGCCGAGGGATCATTGTTCTCCTGA	DLEAARGALDVFEVDALGLDRLDRQVLEALCTRFGGGPVGLTTLAVSVGEEPETVETVAEPYLVREGLVVRTPRGRAATPAAYSHLGLEPPAEGSLFS	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARSIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL	33.68	gnl|BL_ORD_ID|557|hsp_num:0	591
NODE_27752_length_652_cov_5.27806_3 # 512 # 652 # -1 # ID=18508_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.418	NODE_27752_length_652_cov_5.27806_3 	512	652	-	Loose	700	20.4014	vanWI	47.06	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	GACGATAAAGAAATGTTAGAAGATTTAATCGCGGCCGCTTTTAACGATGCGGTACGTCGTGCAGAAGAATTACAAAAAGAAAAGATGGCATCGGTTACTGCGGGAATGCCATTGCCTCCAGGAATGAAGTTTCCATTTTAA	DDKEMLEDLIAAAFNDAVRRAEELQKEKMASVTAGMPLPPGMKFPF	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	12.33	gnl|BL_ORD_ID|2107|hsp_num:0	2242
NODE_28157_length_645_cov_3.12373_1 # 74 # 430 # -1 # ID=18692_1;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.291	NODE_28157_length_645_cov_3.12373_1 	74	430	-	Strict	770	24.2534	mdsA	100.0	3000789	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAGAAAATATTCGGAGCGATAACTTTTATTGCGGCGATTGGTGGCGTTATTTATATGAAAAATAATCCTAAATATAAAGAGATTGTTAGAGTCGTGAAAACTGCTGATGCACGTGGTTTTTACGAAAAAATAATTTTAGAAAAAGATAAACTTGCATTCACAGCAAAAGCAAAAATTAAAGATTATAAGATTGATTATGAGAGTATTAGAAATGTCGGAGAGAAAATTTACGCACGTCTAATAGTGAATAATGACGAGAAGTTAAATATCGATACAGTTATTAATGAAAAAGATACAAATGTAGAAGAAGTATCGCATTCAGAAAAACTGGATGAATTGTTGAATAAATAG	MKKKIFGAITFIAAIGGVIYMKNNPKYKEIVRVVKTADARGFYEKIILEKDKLAFTAKAKIKDYKIDYESIRNVGEKIYARLIVNNDEKLNIDTVINEKDTNVEEVSHSEKLDELLNK	MLIAGVIAAIGGVIYMAGEALWDKDNAVGPPASAPPPPSVPVAKALSRTLAPTAEFTGFLAAPETVELRSRVGGTLDAISVPEGRLVSRGQLLFQIDPRPFEVALDTAVAQLRQAEVLARQAQADFDRIQRLVASGAVSRKNADDVTATRNARQAQMQSAKAAVAAARLELSWTRITAPIAGRVDRILVTRGNLVSGGVAGNATLLTTIVSHNPMYVYFDIDEATWLKALRHTRSDKNPPVVNMGLTTDNGLPYQGVLDFMGNQMNRSTGTIRARAVIPDPDGMLSPGLFARISLPIGEPRETVLIDDLAVSADQGKNYVLIVGKENQVEYRPVELGQMVDGFRVVTQGVLPGEKIILKGLVRPGMTVAPRLVPMRQNVTDKQTATLTKADGDSAPKAVRQ	29.43	gnl|BL_ORD_ID|402|hsp_num:0	429
NODE_28673_length_637_cov_16.433_1 # 1 # 636 # 1 # ID=18929_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.432	NODE_28673_length_637_cov_16.433_1 	1	636	+	Strict	750	407.527	pmrA	97.17	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	AAGGAGAAATCAGGAACTGCCTTAGGTACTTTGTCTACAGGCGTAGTTGCAGGTACTCTAACTGGTCCCTTTATTGGTGGCTTTATCGCAGAATTATTTGGCATTCGTACTGTTTTCTTACTGGTTGGTAGTTTTCTATTCTTAGCTGCTGTTTTAACTATTTGCTTTATCAAGGAAGATTTTCAACCACTAGCCAAGGAAAAGGCCATCCCAACAAAGGAATTATTTACATCAGTTAAATATCCCTATCTCTTGGTCAACCTCTTTCTGACTAGTTTTGTCATCCAATTTTCAGCCCAATCAATCGGCCCTATCTTAGCTCTGTATGTACGCGACTTAGGCCAGACAGAGAATCTTCTTTTTGTCTCTGGTTTGATTGTATCTAGTATGGGCTTTTCCAGTATGATGAGTGCAGGAGTCATGGGAAAGCTAGGTGACAAGGTGGGCAACCATCGCCTCTTGGTTGTAGCCCAGCTTTATTCAGTCATCATCTATCTTCTTTGTGCCAATGCCTCTAGCCCCTTTCAACTAGGACTCTATCGTTTCCTCTTTGGCTTGGGAACCGGTGCTTTGATTCCCGGAGTTAATGCCCTTCTCAGCAAGATGACGCCCAAAGCTGGTATTTCGAGGGTCTTT	KEKSGTALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAVLTICFIKEDFQPLAKEKAIPTKELFTSVKYPYLLVNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQLYSVIIYLLCANASSPFQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVF	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	53.13	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_29066_length_631_cov_2.57812_2 # 538 # 630 # 1 # ID=19103_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.387	NODE_29066_length_631_cov_2.57812_2 	538	630	+	Loose	375	21.557	fusD	37.93	3003731	protein homolog model	n/a	n/a	fusidic acid	antibiotic inactivation	fusidic acid inactivation enzyme	ATGGAAGAAAATAGACGATTGATTATTTTAAATGACACTTTCGGGAAAGATGGGTCAGATGAGGAAATTGCTGGGCTTACGATTTTGGTGGAC	MEENRRLIILNDTFGKDGSDEEIAGLTILVD	MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRNTTIRSNVEKLMNVQLTKEQAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRKFIIYYDNFGKLNGVYGDISNQTVKSFCSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQISDLSHFHHFLNKIQ	14.55	gnl|BL_ORD_ID|2109|hsp_num:0	2248
NODE_29479_length_625_cov_8.03509_1 # 3 # 86 # -1 # ID=19278_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.321	NODE_29479_length_625_cov_8.03509_1 	3	86	-	Strict	600	19.631	Burkholderia pseudomallei Omp38	100.0	3004123	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAACGCGATTCAAGAATCATTTACTGATAAATTATTTGCCAACTATGAAGCAAATGTAAAATACCAAGCGATTGAAAATGCT	MNAIQESFTDKLFANYEANVKYQAIENA	MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQSRFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYDATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFSNNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQGRSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAYTYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTSINQTAATVGLRHRF	7.49	gnl|BL_ORD_ID|2317|hsp_num:0	2786
NODE_29786_length_620_cov_2.19292_1 # 2 # 166 # -1 # ID=19405_1;partial=10;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.624	NODE_29786_length_620_cov_2.19292_1 	2	166	-	Loose	500	24.2534	OXA-18	36.36	3001413	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGTCGTCGAATCGGTCCTACTAGTAGCGCAACAAGGTGCCGGCCCGGTGGGGTCGGAGTTTGGTAAAGCCTCACCCATCGGCTGGTTTGTGATCGTGGCGCTGCTCGCCGCGGTGCTGTTTCTCGGGTGGGCGTTCCACCTCCGCTATAGTCGCATGAATCGG	VVVESVLLVAQQGAGPVGSEFGKASPIGWFVIVALLAAVLFLGWAFHLRYSRMNR	MQRSLSMSGKRHFIFAVSFVISTVCLTFSPANAAQKLSCTLVIDEASGDLLHREGSCDKAFAPMSTFKLPLAIMGYDADILLDATTPRWDYKPEFNGYKSQQKPTDPTIWLKDSIVWYSQELTRRLGESRFSDYVQRFDYGNKDVSGDPGKHNGLTHAWLASSLKISPEEQVRFLRRFLRGELPVSEDALEMTKAVVPHFEAGDWDVQGKTGTGSLSDAKGGKAPIGWFIGWATRDDRRVVFARLTVGARKGEQPAGPAARDEFLNTLPALSENF	20.00	gnl|BL_ORD_ID|964|hsp_num:0	1003
NODE_34044_length_565_cov_2.09608_1 # 1 # 72 # 1 # ID=21115_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.639	NODE_34044_length_565_cov_2.09608_1 	1	72	+	Loose	500	20.7866	aadK	61.54	3002627	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	GCCAAGACCGATGCGCCCACCCGGGCCGCAGCAGTGCATATCGCCGCCCAGAAGGGCTGGATCATTCAGTAA	AKTDAPTRAAAVHIAAQKGWIIQ	MRSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQWLEIFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGLVKVLLDKDSFINYKVTPNDRQYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAIDHLNEIVRPNLLRMMAWHIASQKGYSFSMGKNYKFMKRYLSNKEWEELMSTYSVNGYQEMWKSLFTCYALFRKYSKAVSEGLAYKYPDYDEGITKYTEGIYCSVK	8.10	gnl|BL_ORD_ID|399|hsp_num:0	426
NODE_39440_length_510_cov_38.8352_2 # 439 # 510 # 1 # ID=23112_2;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=6bp;gc_cont=0.333	NODE_39440_length_510_cov_38.8352_2 	439	510	+	Strict	650	18.4754	vanL	100.0	3002910	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGAAAAAGGAGAATATGATGAGTCAAAAGATTATTGGGATTGACCTTGGTGGAACTTCTATCAAATTTGCA	MKKENMMSQKIIGIDLGGTSIKFA	MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDIEYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNIPYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKPNEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDEVSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSDNNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG	6.88	gnl|BL_ORD_ID|326|hsp_num:0	349
NODE_334_length_6651_cov_3.5595_6 # 3454 # 4077 # -1 # ID=334_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.402	NODE_334_length_6651_cov_3.5595_6	3454	4077	-	Strict	400	427.172	tetR	100.0	3003479	protein overexpression model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCTAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAAGGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAAAATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCTTTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGTCATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAATCAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGGCATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCTACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCAGCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGTGAAAGTGGGTCTTAA	MSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	99.52	gnl|BL_ORD_ID|459|hsp_num:0	276
